Impaired clopidogrel antiplatelet effects and age: Young patients at risk

Int J Cardiol. 2015:187:216-8. doi: 10.1016/j.ijcard.2015.03.320. Epub 2015 Mar 24.

Authors

Amin Polzin¹, Malte Kelm², Tobias Zeus²

Affiliations

¹ Division of Cardiology, Pulmonology, and Vascular Medicine, Heinrich Heine University Medical Center Düsseldorf, Düsseldorf, Germany. Electronic address: Amin.polzin@med.uni-duesseldorf.de.
² Division of Cardiology, Pulmonology, and Vascular Medicine, Heinrich Heine University Medical Center Düsseldorf, Düsseldorf, Germany.

PMID: 25838216
DOI: 10.1016/j.ijcard.2015.03.320

No abstract available

Keywords: Age; Clopidogrel; HPR; HTPR; PRI.

Publication types

Letter
Observational Study

MeSH terms

Age Factors
Aged
Aged, 80 and over
Blood Platelets / drug effects*
Clopidogrel
Female
Humans
Male
Middle Aged
Platelet Aggregation Inhibitors / pharmacology*
Risk Factors
Ticlopidine / analogs & derivatives*
Ticlopidine / pharmacology
Treatment Failure

Substances

Platelet Aggregation Inhibitors
Clopidogrel
Ticlopidine